Veincentre is a leading private provider of Varicose vein treatments, founded in 2003 by husband and wife, Dr David West and Deborah West.
Palatine Private Equity’s Impact Fund invested in the business in 2019 and substantially grew the clinic base across the UK. The business has focused on increasing the accessibility and affordability of treatment; serving to both alleviate the burden on the NHS and increasing the number of individuals who have benefited.
Having invested in and successfully exited SpaMedica earlier in the year, with healthcare & pharmaceuticals being a core sector, CBPE were both management’s and the founder’s preferred partner based on their extensive knowledge of private healthcare clinic rollouts and commitment to the delivery of the Veincentre values.
We were selected as lead adviser due to our sector expertise combined with regional service delivery and private equity experience.
We assisted the vendors to commission commercial and financial due diligence. This was vital in helping potential bidders to understand both the growth trends in the underlying market and the future growth potential of the business.
We approached both trade and private equity bidders, using the due diligence materials to run a highly competitive process that was carefully managed given the rapidly evolving macroeconomic climate.
Our strong understanding of the business and the market backdrop enabled us to position the asset in the optimal way, delivering a fantastic result for our client.
Grant Thornton provided an outstanding service throughout, combining their healthcare sector expertise and regional presence to deliver a fantastic result for all shareholders. They worked hard throughout the process to optimise value and find the right partner for the business going forward.
James Painter Investment Director, Palatine Private Equity LLP
